South Korean hospitals are facing critical shortages of medical consumables as the Iran-Israel war disrupts the supply of crude oil and naphtha [1].
The instability in the Middle East is impacting the production of essential plastic-based medical tools. Because these items rely on naphtha, a petroleum derivative, manufacturers are struggling to fulfill orders, forcing healthcare providers to navigate rising costs and dwindling inventories [1, 2].
Prices for naphtha-based medical consumables have risen by approximately 30% overall [1]. Some individual items have seen price increases ranging from 15% to 30% [1]. These costs are being passed down to hospitals, which must now manage tighter budgets to maintain basic patient care [1, 2].
Supply levels have reached a precarious state at several facilities, including Chungbuk National University Hospital [1, 2]. Current inventories of syringes have dropped to just two weeks of stock [1]. Other essential items, such as IV fluids, are currently available for only two to three weeks [1].
Medical supply distributors said the disruption of crude oil supplies limits the ability of manufacturers to maintain steady production. This bottleneck creates a ripple effect that begins at the refinery and ends in the hospital ward [1, 2].
Healthcare administrators are monitoring the situation closely as the conflict persists. The reliance on oil-derived plastics means that any prolonged instability in the region could lead to more severe shortages of sterile equipment, and basic delivery systems for medication [1, 2].
“Prices for naphtha-based medical consumables have risen by approximately 30% overall.”
This crisis highlights the vulnerability of global healthcare supply chains to geopolitical volatility. Because a vast array of sterile medical equipment is derived from petrochemicals, regional conflicts in oil-producing zones can translate directly into clinical shortages, potentially compromising patient safety if inventory buffers are exhausted.
